Text Size
301 studies found for:    "Anaplastic astrocytoma"

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
"Anaplastic astrocytoma"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Oral Tarceva Study for Recurrent/Residual Glioblastoma Multiforme and Anaplastic Astrocytoma
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma
Intervention: Drug: Erlotinib
2 Terminated Efficacy and Safety of AP 12009 in Patients With Recurrent or Refractory Anaplastic Astrocytoma or Secondary Glioblastoma
Conditions: Anaplastic Astrocytoma;   Glioblastoma
Interventions: Drug: trabedersen;   Drug: temozolomide;   Device: Drug delivery system for administration of AP 12009;   Procedure: Placement of Drug Delivery System;   Drug: carmustine;   Drug: lomustine
3 Recruiting Temozolomide and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Astrocytoma
Condition: Glioblastoma Multiforme/Anaplastic Astrocytoma
Interventions: Drug: temozolomide;   Radiation: radiation therapy;   Radiation: stereotactic radiotherapy
4 Recruiting Super-Selective Intraarterial Cerebral Infusion of Cetuximab for the Treatment of Recurrent Glioblastoma Multiforme and Anaplastic Astrocytoma
Conditions: Glioblastoma Multiforme (GBM);   ANAPLASTIC ASTROCYTOMA (AOA)
Intervention: Drug: Superselective Intraarterial Cerebral Infusion of Cetuximab
5 Recruiting Trial Of Super-Selective Intraarterial Cerebral Infusion Of Temozolomide (TEMODAR) For Treatment Of Newly Diagnosed Glioblastoma Multiforme And Anaplastic Astrocytoma
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma
Intervention: Drug: Super-Selective Intraarterial Intracranial Infusion of Temozolomide
6 Recruiting Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab Plus Carboplatin For Treatment Of Relapsed/Refractory GBM And Anaplastic Astrocytoma
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma
Intervention: Drug: Bevacizumab and Carboplatin
7 Recruiting Phase I/II Trial of the Safety, Tolerability, and Anti-tumor Efficacy of AXL1717 (Picropodophyllin) in the Treatment of Recurrent Malignant Astrocytomas
Conditions: Glioblastoma;   Gliosarcoma;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Oligoastrocytoma;   Anaplastic Ependymoma
Intervention: Drug: AXL1717
8 Completed
Has Results 		A Phase II Trial of Sutent (Sunitinib; SU011248) for Recurrent Anaplastic Astrocytoma and Glioblastoma
Conditions: Anaplastic Astrocytoma;   Glioblastoma
Intervention: Drug: Sunitinib Malate
9 Recruiting Trial Of Repeated Super-selective Intraarterial Cerebral Infusion Of Bevacizumab (Bevacizumab) For Treatment Of Relapsed/Refractory Glioblastoma Multiforme And Anaplastic Astrocytoma.
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma
Intervention: Drug: Bevacizumab
10 Recruiting A Phase I Trial of Nanoliposomal CPT-11 (NL CPT-11) in Patients With Recurrent High-Grade Gliomas
Conditions: Glioblastoma;   Gliosarcoma;   Anaplastic Astrocytoma;   Anaplastic Oligodendroglioma;   Anaplastic Mixed Oligoastrocytoma;   Malignant Astrocytoma NOS
Intervention: Drug: Nanoliposomal CPT-11
11 Terminated The Effect of Radiotherapy and Temozolomide on the Tumor Vasculature and Stem Cells in Human High-grade Astrocytomas
Conditions: Anaplastic Astrocytoma;   Glioblastoma Multiforme;   Tumor Angiogenesis
Interventions: Device: Functional MRI (DCE-MRI);   Procedure: Blood sample;   Procedure: Tumor sample
12 Completed BNCT to Treat Glioma That Has Progressed Following Radiotherapy
Conditions: Glioblastoma;   Anaplastic Astrocytoma
Intervention: Radiation: Bononophenylalanine (BPA)-based BNCT
13 Completed Phase IIa Safety and Light Dose-escalation Study in Patients With Primary or Recurrent/High-grade Glioma Using the Litx™ System to Confirm the Zone of Tumor Destruction During the Intraoperative Treatment of Glioma
Conditions: Glioma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma
Interventions: Drug: LS11 (talaporfin sodium);   Device: Light source (interstitial light emitting diodes);   Procedure: Intraoperative placement of device in glioma
14 Completed Histologic Effect/Safety of Pre/Post-Operative IL13-PE38QQR in Recurrent Resectable Supratentorial Malignant Glioma Patients
Conditions: Malignant Glioma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   Mixed Oligoastrocytoma;   Malignant Astrocytoma
Interventions: Drug: IL13-PE38QQR;   Procedure: targeted fusion protein therapy;   Procedure: surgery
15 Recruiting Super-Selective Intraarterial Intracranial Infusion of Avastin (Bevacizumab)
Conditions: Glioblastoma Multiforme;   Anaplastic Astrocytoma
Intervention: Drug: Super-Selective Intraarterial Intracranial Infusion of BEVACIZUMAB
16 Completed Radiotherapy for Malignant Astrocytomas in the Elderly
Conditions: Primary Brain Tumor;   Anaplastic Astrocytoma;   Glioblastoma Multiforme
Intervention: Drug: Radiotherapy
17 Completed Phase III Trial of Primary Radio- or Chemotherapy in Malignant Astrocytoma of the Elderly
Conditions: Glioblastoma;   Anaplastic Astrocytoma
Interventions: Drug: Temozolomide;   Radiation: Radiotherapy of the partial brain.
18 Recruiting A Study of PD 0332991 in Patients With Recurrent Rb Positive Glioblastoma
Conditions: Glioblastoma;   Gliosarcoma;   Anaplastic Astrocytoma
Intervention: Drug: PD 0332991
19 Active, not recruiting Sorafenib in Newly Diagnosed High Grade Glioma
Conditions: Glioblastoma;   Gliosarcoma;   Anaplastic Astrocytoma;   Anaplastic Oligoastrocytoma;   Anaplastic Oligodendroglioma
Intervention: Drug: Sorafenib dose escalation
20 Not yet recruiting Dendritic Cell Vaccine For Malignant Glioma and Glioblastoma Multiforme in Adult and Pediatric Subjects
Conditions: Malignant Glioma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   High Grade Glioma
Interventions: Biological: Dendritic Cell Vaccine;   Biological: Tumor Lysate;   Other: Imiquimod;   Procedure: Leukapheresis
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years